Jump to content

WHO Halts Hydroxychloroquine Trial

Updated | Posted

Specializes in Education, FP, LNC, Forensics, ED, OB. Has 30 years experience.


The World Health Organization says it is temporarily halting its clinical trials that use hydroxychloroquine to treat COVID-19 patients over published concerns that the drug may do more harm than good.

The move comes after the medical journal The Lancet reported on Friday that patients getting hydroxychloroquine were dying at higher rates than other coronavirus patients.


The trials being put on hold by the WHO are investigating its use as a treatment for patients who are hospitalized with COVID-19, not as a drug to prevent the disease.

What is your opinion about hydroxychloroquine and the COVID-19?

Read in its entirety: WHO Halts Hydroxychloroquine Trial Over Safety Concerns

tnbutterfly - Mary, BSN, RN

Specializes in Peds, Med-Surg, Disaster Nsg, Parish Nsg.


GENEVA (Reuters) - The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.


The WHO's director-general, Tedros Adhanom Ghebreyesus, said its experts had advised the continuation of all trials including hydroxychloroquine, whose highest-profile backer for use against the coronavirus is U.S. President Donald Trump.

Read the entire story: WHO Set to Resume Hydroxychloroquine Trial in Battle Against COVID-19

What do you think of this change?

herring_RN, ASN, BSN

Specializes in Critical care, tele, Medical-Surgical. Has 49 years experience.

The FDA just revoked an emergency OK for the malaria pill hydroxychloroquine in coronavirus patients, as clinical evidence piles up against the drug

  • US health regulators will no longer allow the emergency use of chloroquine or hydroxychloroquine to treat COVID-19.
  • The Food and Drug Administration said Monday it has revoked the emergency use authorization issued for the antimalarial medications.
  • The FDA had previously allowed the drugs to be used in hospitalized COVID-19 patients. Clinical trials testing hydroxychloroquine will not be affected by the change.
  • FDA reviewers concluded that chloroquine and hydroxychloroquine "are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA."
  • The decision also acknowledged "serious" heart-related side effects that the pills can cause...

... An emergency use OK is not full FDA approval. The bar of evidence is lower for emergency use, allowing regulators to consider both the potential and known benefits and risks for a drug. Standard approval requires the demonstrated benefits outweigh the known risks....